Showing results (951-960 of 975) with videos related to
Sort By:
Pageof 98
European Journal of Nuclear Medicine and Molecular Imaging|October 27, 2022
Benefit of [18F] FDG PET/CT in the diagnosis and salvage treatment of recurrent nasopharyngeal carcinomaPu-Yun OuYang, Zhi-Qiao Liu, Qing-Guang Lin, et al.Journal of Orthopaedic Translation|October 21, 2024
The CD163/TWEAK/Fn14 axis: A potential therapeutic target for alleviating inflammatory bone lossJi-Kun Qian, Yuan Ma, Xuan Huang, et al.Communications Medicine|March 30, 2026
Machine learning survival model for personalised prevention of catheter-related thrombosis in tumour patientsHewei Ge, Qiao Liu, Junying Xie, et al.Acta Pharmacologica Sinica|April 24, 2023
DHX9/DNA-tandem repeat-dependent downregulation of ciRNA-Fmn1 in the dorsal horn is required for neuropathic painXiao-Dan Liu, Tong Jin, Yang Tao, et al.Proceedings of the National Academy of Sciences of the United States of America|June 15, 2026
The global diversity and decline of glacier animalsAndrea Simoncini, Isabel Cantera, Simone Giachello, et al.Expert Review of Vaccines|November 11, 2024
Immunogenicity and safety of two-dose or three-dose regimens of inactivated COVID-19 vaccines in patients with pulmonary tuberculosis: a randomised clinical trialPengfei Jin, Qiao Liu, Wenli Chen, et al.Nature Communications|September 22, 2023
The NCOR-HDAC3 co-repressive complex modulates the leukemogenic potential of the transcription factor ERGEitan Kugler, Shreyas Madiwale, Darren Yong, et al.Nature Medicine|July 18, 2018
Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancerSeung Tae Kim, Razvan Cristescu, Adam J Bass, et al.Cell|October 8, 2022
The primordial differentiation of tumor-specific memory CD8+ T cells as bona fide responders to PD-1/PD-L1 blockade in draining lymph nodesQizhao Huang, Xia Wu, Zhiming Wang, et al.Science (New York, N.Y.)|October 13, 2018
Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapyRazvan Cristescu, Robin Mogg, Mark Ayers, et al.Pageof 98